FCV-VBS isolated from cats with typical symptoms caused VSD in experimental cats.
Commercially available vaccines have been used widely to prevent feline calicivirus infection (FCI). However, with their widespread use, field strains, which are weakly cross-reactive with the live-virus vaccine strain F9, have posed the problem of vaccine breakdown. Recently the existence of FCV--associated virulent systemic disease (VSD) has been published. But their molecular diversity, antigenic mutations and physicochemical property have not been sufficiently clarified. Thus, we experimentally gave the vaccine breakdown strain (VBS) H10 to cats that had been inoculated with an F9 live vaccine. After the administration of strain H10, vaccinated cats (1 through 4) had no respiratory symptoms, whereas the non-vaccinated cat 5 showed clinical symptoms such as a fever of over 40 degrees C, loss of vitality, decreased appetite, diarrhea, and nasal discharge after receiving strain H10, and died. Lethal FCV is rare, and may be a virulent systemic disease (VSD)--inducing strain. This is the initial report on VSD in Japan. It has been reported that symptoms of VSD were similar in vaccinated and nonvaccinated cats on experimental infection. However, no VSD-like symptoms developed, and the incidence of the disease varied depending on the presence or absence of vaccination, suggesting that there are two mechanisms of vaccine breakdown: one is associated with the vaccine immunity level, and the other is not. The characteristics of the VBS revealed were: (1) the duration of virus excretion was short when the originally carried antibody titer before virus challenge was high, (2) the excreted viral molecular species varied daily, not being limited to a specific species with time, and (3) the acquired physicochemical properties did not persist, and altered daily. FCV-VBS alters the molecular species and physicochemical properties daily due to the reduction of host immunity, which may lead to VSD.
Ohe
Kyoko
K
Department of Infectious diseases & Pathology, University of Florida, College of Veterinary Medicine, PO Box 110880, Gainesville, FL 32611-0880, USA.
Takahashi
Toshikazu
T
Hara
Daisuke
D
Hara
Motonobu
M
D000818:Animals; D000914:Antibodies, Viral / Q000097:blood; D001483:Base Sequence; D017250:Caliciviridae Infections / Q000097:blood / Q000276:immunology / Q000662:veterinary* / Q000821:virology; D017927:Calicivirus, Feline / Q000235:genetics / Q000276:immunology / Q000302:isolation & purification*; D002371:Cat Diseases / Q000097:blood / Q000276:immunology / Q000821:virology*; D002415:Cats; D008969:Molecular Sequence Data; D017354:Point Mutation; D013047:Specific Pathogen-Free Organisms; D013997:Time Factors; D014765:Viral Vaccines / Q000276:immunology; D017201:Virus Shedding
D000914:Antibodies, Viral; D014765:Viral Vaccines